GB1182124A - Process for the production of Pharmaceutical and like Beadlets - Google Patents
Process for the production of Pharmaceutical and like BeadletsInfo
- Publication number
- GB1182124A GB1182124A GB20981/67A GB2098167A GB1182124A GB 1182124 A GB1182124 A GB 1182124A GB 20981/67 A GB20981/67 A GB 20981/67A GB 2098167 A GB2098167 A GB 2098167A GB 1182124 A GB1182124 A GB 1182124A
- Authority
- GB
- United Kingdom
- Prior art keywords
- aluminium
- solvent
- bed
- polymer
- polymers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920000642 polymer Polymers 0.000 abstract 4
- 159000000013 aluminium salts Chemical class 0.000 abstract 3
- 239000011324 bead Substances 0.000 abstract 3
- 239000002904 solvent Substances 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- JCIIKRHCWVHVFF-UHFFFAOYSA-N 1,2,4-thiadiazol-5-amine;hydrochloride Chemical compound Cl.NC1=NC=NS1 JCIIKRHCWVHVFF-UHFFFAOYSA-N 0.000 abstract 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003905 agrochemical Substances 0.000 abstract 1
- MANKSFVECICGLK-UHFFFAOYSA-K aloxiprin Chemical compound [OH-].[Al+3].CC(=O)OC1=CC=CC=C1C([O-])=O.CC(=O)OC1=CC=CC=C1C([O-])=O MANKSFVECICGLK-UHFFFAOYSA-K 0.000 abstract 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- 239000004411 aluminium Substances 0.000 abstract 1
- 229910000329 aluminium sulfate Inorganic materials 0.000 abstract 1
- 230000000954 anitussive effect Effects 0.000 abstract 1
- 230000001539 anorectic effect Effects 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- -1 antichlorinergic Substances 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229940124584 antitussives Drugs 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 229940096529 carboxypolymethylene Drugs 0.000 abstract 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000850 decongestant Substances 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002363 herbicidal effect Effects 0.000 abstract 1
- 239000004009 herbicide Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000005609 naphthenate group Chemical group 0.000 abstract 1
- 125000005474 octanoate group Chemical group 0.000 abstract 1
- 229940096826 phenylmercuric acetate Drugs 0.000 abstract 1
- 229920002689 polyvinyl acetate Polymers 0.000 abstract 1
- 239000011118 polyvinyl acetate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000011877 solvent mixture Substances 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL131321D NL131321C (enrdf_load_stackoverflow) | 1967-05-05 | ||
| FR104134A FR6327M (enrdf_load_stackoverflow) | 1967-05-05 | 1967-04-25 | |
| DE19671667062 DE1667062A1 (de) | 1967-05-05 | 1967-04-28 | Verfahren zur Herstellung kleiner kugelfoermiger Perlen |
| NL6706319A NL6706319A (enrdf_load_stackoverflow) | 1967-05-05 | 1967-05-05 | |
| GB20981/67A GB1182124A (en) | 1967-05-05 | 1967-05-05 | Process for the production of Pharmaceutical and like Beadlets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB20981/67A GB1182124A (en) | 1967-05-05 | 1967-05-05 | Process for the production of Pharmaceutical and like Beadlets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1182124A true GB1182124A (en) | 1970-02-25 |
Family
ID=10155145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB20981/67A Expired GB1182124A (en) | 1967-05-05 | 1967-05-05 | Process for the production of Pharmaceutical and like Beadlets |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE1667062A1 (enrdf_load_stackoverflow) |
| FR (1) | FR6327M (enrdf_load_stackoverflow) |
| GB (1) | GB1182124A (enrdf_load_stackoverflow) |
| NL (2) | NL6706319A (enrdf_load_stackoverflow) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0086704A1 (fr) * | 1982-02-15 | 1983-08-24 | MICROENCAPSULATION S.A. Société dite: | Procédé et appareil pour la production de granules parfaitement sphériques et poreux, et granules ainsi obtenus |
| US4642233A (en) * | 1982-03-22 | 1987-02-10 | Alza Corporation | Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills |
| US4649043A (en) * | 1982-03-22 | 1987-03-10 | Alza Corporation | Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract |
| US4659558A (en) * | 1982-03-22 | 1987-04-21 | Alza Corporation | Oral delivery system comprising a plurality of tiny pills for delivering drug in the stomach and intestine |
| US4764380A (en) * | 1982-03-22 | 1988-08-16 | Alza Corporation | Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills |
| US4851232A (en) * | 1987-02-13 | 1989-07-25 | Alza Corporation | Drug delivery system with means for obtaining desirable in vivo release rate pattern |
| US5122384A (en) * | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US9974752B2 (en) | 2014-10-31 | 2018-05-22 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
-
0
- NL NL131321D patent/NL131321C/xx active
-
1967
- 1967-04-25 FR FR104134A patent/FR6327M/fr not_active Expired
- 1967-04-28 DE DE19671667062 patent/DE1667062A1/de active Pending
- 1967-05-05 NL NL6706319A patent/NL6706319A/xx unknown
- 1967-05-05 GB GB20981/67A patent/GB1182124A/en not_active Expired
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0086704A1 (fr) * | 1982-02-15 | 1983-08-24 | MICROENCAPSULATION S.A. Société dite: | Procédé et appareil pour la production de granules parfaitement sphériques et poreux, et granules ainsi obtenus |
| US4642233A (en) * | 1982-03-22 | 1987-02-10 | Alza Corporation | Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills |
| US4649043A (en) * | 1982-03-22 | 1987-03-10 | Alza Corporation | Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract |
| US4659558A (en) * | 1982-03-22 | 1987-04-21 | Alza Corporation | Oral delivery system comprising a plurality of tiny pills for delivering drug in the stomach and intestine |
| US4764380A (en) * | 1982-03-22 | 1988-08-16 | Alza Corporation | Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills |
| US4851232A (en) * | 1987-02-13 | 1989-07-25 | Alza Corporation | Drug delivery system with means for obtaining desirable in vivo release rate pattern |
| US5122384A (en) * | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5296232A (en) * | 1989-05-05 | 1994-03-22 | Kv Pharmaceutical Company | Pharmaceutical formulation which does not induce tolerance |
| US5445829A (en) * | 1989-05-05 | 1995-08-29 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US9974752B2 (en) | 2014-10-31 | 2018-05-22 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US10111839B2 (en) | 2014-10-31 | 2018-10-30 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US10292938B2 (en) | 2014-10-31 | 2019-05-21 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US10292939B2 (en) | 2014-10-31 | 2019-05-21 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US10449159B2 (en) | 2014-10-31 | 2019-10-22 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US10500162B2 (en) | 2014-10-31 | 2019-12-10 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US10507186B2 (en) | 2014-10-31 | 2019-12-17 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US10512613B2 (en) | 2014-10-31 | 2019-12-24 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US10512612B2 (en) | 2014-10-31 | 2019-12-24 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US10568841B2 (en) | 2014-10-31 | 2020-02-25 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US10688060B2 (en) | 2014-10-31 | 2020-06-23 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US11896722B2 (en) | 2014-10-31 | 2024-02-13 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1667062A1 (de) | 1971-06-03 |
| NL6706319A (enrdf_load_stackoverflow) | 1968-11-06 |
| NL131321C (enrdf_load_stackoverflow) | |
| FR6327M (enrdf_load_stackoverflow) | 1968-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3853566T2 (de) | Formulierungen von Tetrazyklinverbindungen mit kontrollierter Freisetzung. | |
| DE3751860T2 (de) | Verwendung von spezifischem Kernmaterial und Schichten zur Herstellung pharmazeutischer Formulierungen, die stabil gegen die Verfärbung von Omeprazol sind | |
| DE3751851T2 (de) | Verwendung von spezifischem Kernmaterial und Schichten zur Herstellung pharmazeutischer Formulierungen, die stabil gegen die Verfärbung säurelabiler Verbindungen sind | |
| EP0339506B1 (de) | Orales osmotisches System mit verbesserter Haftwirkung der Membran am Kern | |
| DE2336218A1 (de) | Neue orale arzneiform und verfahren zu ihrer herstellung | |
| GB1182124A (en) | Process for the production of Pharmaceutical and like Beadlets | |
| KR930012006A (ko) | 액상분산 소수성중합체 코팅 방출억제성 안정화 기질 | |
| KR840005016A (ko) | 서방출성 정제의 제조방법 | |
| ES388698A1 (es) | Procedimiento para la preparacion de pequenas bolitas medi-camentosas para administracion oral con un revestimiento re-tardador de la liberacion de sustancia activa. | |
| KR20000071247A (ko) | 활성 물질이 조절 방출되는 오피오이드 진통제 | |
| KR860002271A (ko) | 조절되게 방출되게끔(controlled-release) 코오팅된 조제학상의 제제와 그 제제의 제조방법 | |
| IE82916B1 (en) | Formulations and their use in the treatment of neurological diseases | |
| CA2016039A1 (en) | Extended release pharmaceutical formulations | |
| NZ220875A (en) | A sustained release pharmaceutical composition in oral dosage form comprising a core matrix, a medicament and a coating layer | |
| NZ238131A (en) | Chewable medicament tablets formed from compressed coated granules; coating is a polymer blend masking taste and providing sustained release | |
| NZ228076A (en) | Pharmaceutical compositions containing basifying agents | |
| RU2008136766A (ru) | Таблетки метопролола сукцината пролонгированного действия и способы их приготовления | |
| CA2129099A1 (en) | Pharmaceutical compositions having good dissolution properties | |
| JPH01502754A (ja) | 薬学的製剤 | |
| CA2344372A1 (en) | Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same | |
| KR890003376A (ko) | Dhp 축적질 제제물 | |
| CH634748A5 (de) | Ueberzugsmaterial zur geregelten wirkstoffabgabe von arzneimitteln sowie verfahren zu dessen herstellung. | |
| BR112020021989A2 (pt) | formulação farmacêutica estável | |
| DE69108007T2 (de) | Verfahren zur herstellung einer einen wärme-, licht- und feuchtigkeit empfindlichen wirkstoff mit einer monoklinisch kristallinen struktur enthaltenden tabletten oder dragee zusammensetzung. | |
| EP0070127A2 (en) | Tablets |